← FDA DRUG APPROVALS

FDA NDA · NDA018865

BETAMETHASONE VALERATE

Sponsor: FOUGERA

APPLICATION
NDA018865
TYPE
NDA
ORIGINAL APPROVAL
1983-08-31
LATEST ACTION
2015-01-20
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

BETAMETHASONE VALERATE · ReferencePrescription
BETAMETHASONE VALERATE EQ 0.1% BASE · OINTMENT · TOPICAL

Approval history

2015-01-20Manufacturing (CMC) · Supplement 13AP
1996-12-12Labeling · Supplement 11AP
1996-04-29Manufacturing (CMC) · Supplement 9AP
1996-03-07Manufacturing (CMC) · Supplement 10AP
1988-10-24Manufacturing (CMC) · Supplement 6AP
1988-09-14Labeling · Supplement 8AP
1987-04-23Manufacturing (CMC) · Supplement 5AP
1987-04-23Manufacturing (CMC) · Supplement 4AP
1983-08-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →